Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001073406 | SCV001238947 | uncertain significance | Retinal dystrophy | 2019-01-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001862803 | SCV002187458 | uncertain significance | Retinitis pigmentosa 12; Leber congenital amaurosis 8 | 2021-08-11 | criteria provided, single submitter | clinical testing | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CRB1 protein function. This sequence change replaces cysteine with tyrosine at codon 1283 of the CRB1 protein (p.Cys1283Tyr). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and tyrosine. This variant is not present in population databases (ExAC no frequency). This missense change has been observed in individual(s) with Leber congenital amaurosis (Invitae). ClinVar contains an entry for this variant (Variation ID: 865861). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome- |
RCV003455317 | SCV004180193 | uncertain significance | Leber congenital amaurosis 8 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003455318 | SCV004180194 | uncertain significance | Pigmented paravenous retinochoroidal atrophy | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003455316 | SCV004180195 | uncertain significance | Retinitis pigmentosa 12 | 2023-04-11 | criteria provided, single submitter | clinical testing |